Sign inJoin waitlistJoin the waitlist

Joe Stephenson

Clinical Associate Professor · University of South Carolina-Columbia

Credentials: · · · · ·

History

University of South Carolina-Columbia
Present

Hematology and Medical Oncology
1994–1997
Internal Medicine
1991–1994
Med Univ of South Carolina Coll of Med
1987–1991

Research

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Nature · 2011 · 462 citations
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors
Clinical Cancer Research · 2017 · Last of 11 authors · 172 citations
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Annals of Oncology · 2012 · 166 citations

DR
Donald Richards
6 papers
JN
John Nemunaitis
6 papers
DH
Daniel Von Hoff
5 papers
ER
Eric Rowinsky
4 papers
HB
Howard Burris
4 papers
LG
Lawrence Garbo
4 papers
LS
Lee Schwartzberg
3 papers
LS
Lon Smith
3 papers
AC
Allen Cohn
2 papers
AT
Anthony Tolcher
2 papers
Antoni Ribas
2 papers
CB
Carlos Becerra
2 papers

Clinical trials

Prevent Cancer- Greenville
Principal investigator · Recruiting
Prisma Health-Upstate
2018–2029
Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma
Principal investigator · Completed · Phase 1
Progen Pharmaceuticals
2006–2011
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
Site PI · Unknown · Phase 2
Xcyte Therapies
2004